PMC6364128_01
(a) Slit lamp photograph showing the intralenticular Ozurdex implant. (b) Scheimpflug image showing the intralenticular Ozurdex implant together with the intact posterior capsule.
CRIOPM2019-8630504.001.jpg
PMC6364128_01_CRIOPM2019-8630504.001.jpg
fig1
Snellen chart and the IOP was 16 mmHg. Slit lamp examination revealed a Grade II nuclear cataract without anterior chamber inflammation and there was an intralenticular dexamethasone implant in the upper part of the lens (Figure 1(a)). Scheimpflug photograph of the left eye showed the intralenticular Ozurdex implant with an intact posterior capsule (Figure 1(b)).
(a)-(b) Optical Coherence Tomography image showing the macular edema before Ozurdex injection (CMT: 565 mum). (c)-(d) Optical Coherence Tomography images 85 days after the following Ozurdex administration showing resolution of the macular edema (CMT: 290 mum).
CRIOPM2019-8630504.002.jpg
PMC6364128_01_CRIOPM2019-8630504.002.jpg
fig2
Comparison of OCT images of the macular edema prior to Ozurdex injection (central macular thickness (CMT): 565 mum) (Figures 2(a) and 2(b)) and 85 days afterwards (CMT: 290 mum) demonstrated resolution of the edema (Figures 2(c) and 2(d)).